INDO-GLOBAL ENT. | DHANVANTRI JEEV | INDO-GLOBAL ENT./ DHANVANTRI JEEV |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -31.9 | 13.5 | - | View Chart |
P/BV | x | 1.4 | 0.9 | 168.3% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
INDO-GLOBAL ENT. DHANVANTRI JEEV |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
INDO-GLOBAL ENT. Mar-20 |
DHANVANTRI JEEV Mar-24 |
INDO-GLOBAL ENT./ DHANVANTRI JEEV |
5-Yr Chart Click to enlarge
|
||
High | Rs | 20 | 28 | 73.6% | |
Low | Rs | 20 | 10 | 197.9% | |
Sales per share (Unadj.) | Rs | 0 | 49.9 | 0.0% | |
Earnings per share (Unadj.) | Rs | -0.7 | 0.4 | -162.7% | |
Cash flow per share (Unadj.) | Rs | -0.7 | 2.5 | -26.0% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 11.1 | 23.1 | 48.0% | |
Shares outstanding (eoy) | m | 6.37 | 4.10 | 155.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0 | 0.4 | - | |
Avg P/E ratio | x | -31.1 | 47.2 | -66.0% | |
P/CF ratio (eoy) | x | -31.1 | 7.6 | -412.2% | |
Price / Book Value ratio | x | 1.8 | 0.8 | 223.4% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 130 | 78 | 166.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1 | 43 | 1.2% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 0 | 205 | 0.0% | |
Other income | Rs m | 0 | 3 | 0.0% | |
Total revenues | Rs m | 0 | 208 | 0.0% | |
Gross profit | Rs m | -1 | 8 | -17.5% | |
Depreciation | Rs m | 0 | 9 | 0.0% | |
Interest | Rs m | 1 | 0 | 1,150.0% | |
Profit before tax | Rs m | -2 | 3 | -84.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 2 | 1 | 224.4% | |
Profit after tax | Rs m | -4 | 2 | -252.7% | |
Gross profit margin | % | 0 | 4.1 | - | |
Effective tax rate | % | -93.4 | 35.4 | -264.0% | |
Net profit margin | % | 0 | 0.8 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 0 | 50 | 0.1% | |
Current liabilities | Rs m | 7 | 39 | 17.8% | |
Net working cap to sales | % | 0 | 5.7 | - | |
Current ratio | x | 0 | 1.3 | 0.4% | |
Inventory Days | Days | 0 | 33 | - | |
Debtors Days | Days | 0 | 31,291,445 | - | |
Net fixed assets | Rs m | 80 | 100 | 80.0% | |
Share capital | Rs m | 64 | 42 | 153.3% | |
"Free" reserves | Rs m | 7 | 53 | 13.1% | |
Net worth | Rs m | 71 | 95 | 74.6% | |
Long term debt | Rs m | 2 | 0 | - | |
Total assets | Rs m | 80 | 150 | 53.2% | |
Interest coverage | x | -2.1 | 43.5 | -4.9% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0 | 1.4 | 0.0% | |
Return on assets | % | -4.4 | 1.1 | -382.9% | |
Return on equity | % | -5.9 | 1.7 | -338.6% | |
Return on capital | % | -2.0 | 2.8 | -72.7% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -1 | 25 | -5.4% | |
From Investments | Rs m | NA | -4 | -0.0% | |
From Financial Activity | Rs m | 1 | NA | - | |
Net Cashflow | Rs m | 0 | 21 | 0.0% |
Indian Promoters | % | 2.8 | 19.7 | 14.4% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 97.2 | 80.4 | 120.9% | |
Shareholders | 543 | 1,581 | 34.3% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare INDO-GLOBAL ENT. With: APOLLO HOSPITALS NARAYANA HRUDAYALAYA DR. LAL PATHLABS KIMS METROPOLIS HEALTHCARE
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | INDO-GLOBAL ENT. | DHAN JEEVAN |
---|---|---|
1-Day | -4.76% | -4.53% |
1-Month | 6.24% | 9.70% |
1-Year | -13.28% | 59.16% |
3-Year CAGR | -7.78% | 33.94% |
5-Year CAGR | -4.74% | 16.77% |
* Compound Annual Growth Rate
Here are more details on the INDO-GLOBAL ENT. share price and the DHAN JEEVAN share price.
Moving on to shareholding structures...
The promoters of INDO-GLOBAL ENT. hold a 2.8% stake in the company. In case of DHAN JEEVAN the stake stands at 19.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of INDO-GLOBAL ENT. and the shareholding pattern of DHAN JEEVAN.
Finally, a word on dividends...
In the most recent financial year, INDO-GLOBAL ENT. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
DHAN JEEVAN paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of INDO-GLOBAL ENT., and the dividend history of DHAN JEEVAN.
After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.